Skip to Main Content
FIND A CLINIC

Disclaimers page

Disclaimers
The information on this Web site is intended for informational and educational purposes only and should not be used as a substitute for advice provided by a qualified, authorised medical practitioner. CoolSculpting® is a CE marked medical device with clinical indications and characteristics. We always recommend consultation with a qualified authorised medical practitioner who will advise the most appropriate product from within the range for your individual needs.

This clinic locator is provided to you as a service aimed at facilitating the interaction with qualified medical practices for independent and professional medical advice relating to aesthetic treatments.

Allergan does not endorse, certify or otherwise promotes the skills, capabilities, qualifications, credentials, expertise and experience of any clinical practice and/or healthcare professional in particular.

The information on this website is intended for informational and educational purposes only and should not be used as a substitute for advice provided by a qualified medical aesthetics practitioner.

Coolsculpting® is a CE marked medical devices with clinical indications and characteristics. We always recommend consultation with a qualified aesthetic medical aesthetics practitioner who will advise the most appropriate treatment from within the range for your individual needs.

Registered office address: AbbVie Limited, Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB
Company registration number: 8004972

The search filters in the locator are provided to improve the search results based on your interests. In any case, the search results are listed based on geographical relevance.


By using the locator and/or navigating on this webpage you agree to the following terms and conditions of use.

    Important safety information

    During the procedure patients may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations may subside as the area becomes numb. Following the procedure, typical side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. These rare and very rare adverse events have the following reported rates (approximate occurrences per number of treatment cycles): paradoxical hyperplasia (1/3000 [0.033%]); late-onset pain (1/6000 [0.017%]); severe pain (1/6000 [0.017%]); hyperpigmentation (1/11000 [0.009%]); freeze burn (1/15000 [0.006%]); treatment area demarcation (1/20000 [0.005%]); vasovagal symptoms (1/30000 [0.003%]); subcutaneous induration (1/30000 [0.003%]); cold panniculitis (1/60000 [0.002%]) and hernia (1/185000 [0.001%]).¹ The CoolSculpting® procedure is not for everyone. Patients should not have the CoolSculpting® procedure if they suffer from cryoglobulinemia, cold agglutinin disease or paroxysmal cold haemoglobinuria.¹ The CoolSculpting® procedure is not a treatment for obesity.² CoolSculpting® is not a weight-loss procedure and should not replace a healthy diet and active lifestyle.

    Treatment results may vary. All models shown have been treated with CoolSculpting®. You should always consult a healthcare professional to help you decide if CoolSculpting® is right for you and provide you with a full list of side effects.

    References

    1. Allergan. CoolSculpting® system user manual. BRZ-101-TUM-EN4-K. August 2020.

    2. FDA 510(K) summary document, January 2020. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf19/K193566.pdf. [June 2024]

    The suitability of CoolSculpting® treatment on an individual patient basis should always be considered as part of the assessment and consultation process. CoolSculpting® is not suitable for all patients. Please consult the ‘Directions for Use’ prior to the procedure. Patient results may vary.

    To learn more about CoolSculpting® and/or CoolSculpting® Elite, please visit https://uk.coolsculpting.com/ for further information. Images are for illustrative purposes only. Promotional material provided by Allergan Aesthetics, an AbbVie company. This content is intended for UK & Ireland adult (>18yrs) audience only.

    HCPs - Adverse Events should be reported.

    UK Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App stores. Adverse events should also be reported to AbbVie on coolsculpting.intlsupport@allergan.com
    Irish HCPs are asked to report any suspected adverse reactions via HPRA Pharmacovigilance website: https://www.hpra.ie.

    Patient - Adverse events should be reported.

    UK - Reporting of Side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at coolsculpting.intlsupport@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.

    Ireland - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via https://www.hpra.ie.

    CoolSculpting®, the CoolSculpting® logo, and the Snowflake design are registered trademarks of Allergan Aesthetics, an AbbVie company. ZELTIQ® is part of Allergan Aesthetics, an AbbVie company. © 2024 AbbVie. All rights reserved.

    For further information on CoolSculpting® please visit https://uk.coolsculpting.com/

    UK-CSC-230197 | August 2024